Analysis  ||| S:0 E:9 ||| NN
on  ||| S:9 E:12 ||| IN
the  ||| S:12 E:16 ||| DT
change  ||| S:16 E:23 ||| NN
of  ||| S:23 E:26 ||| IN
genotype  ||| S:26 E:35 ||| NN
of  ||| S:35 E:38 ||| IN
enteroviruses  ||| S:38 E:52 ||| JJ
associated  ||| S:52 E:63 ||| JJ
hand ||| S:63 E:67 ||| NN
,  ||| S:67 E:69 ||| ,
foot  ||| S:69 E:74 ||| NN
and  ||| S:74 E:78 ||| CC
mouth  ||| S:78 E:84 ||| NN
disease  ||| S:84 E:92 ||| NN
in  ||| S:92 E:95 ||| IN
Beijing  ||| S:95 E:103 ||| NNP
during  ||| S:103 E:110 ||| IN
2013  ||| S:110 E:115 ||| CD
to  ||| S:115 E:118 ||| TO
2014  ||| S:118 E:123 ||| CD
To  ||| S:123 E:126 ||| TO
analyze  ||| S:126 E:134 ||| VB
the  ||| S:134 E:138 ||| DT
genotype ||| S:138 E:146 ||| NN
,  ||| S:146 E:148 ||| ,
epidemic  ||| S:148 E:157 ||| JJ
pattern  ||| S:157 E:165 ||| NN
and  ||| S:165 E:169 ||| CC
the  ||| S:169 E:173 ||| DT
characteristics  ||| S:173 E:189 ||| NN
of  ||| S:189 E:192 ||| IN
the  ||| S:192 E:196 ||| DT
disease  ||| S:196 E:204 ||| NN
of  ||| S:204 E:207 ||| IN
enteroviruses  ||| S:207 E:221 ||| NN
during  ||| S:221 E:228 ||| IN
the  ||| S:228 E:232 ||| DT
epidemic  ||| S:232 E:241 ||| JJ
season  ||| S:241 E:248 ||| NN
of  ||| S:248 E:251 ||| IN
hand ||| S:251 E:255 ||| NN
,  ||| S:255 E:257 ||| ,
foot  ||| S:257 E:262 ||| NN
and  ||| S:262 E:266 ||| CC
mouth  ||| S:266 E:272 ||| NN
disease  ||| S:272 E:280 ||| NN
( ||| S:280 E:281 ||| -LRB-
HMFD ||| S:281 E:285 ||| NNP
)  ||| S:285 E:287 ||| -RRB-
in  ||| S:287 E:290 ||| IN
children  ||| S:290 E:299 ||| NNS
from  ||| S:299 E:304 ||| IN
2013  ||| S:304 E:309 ||| CD
to  ||| S:309 E:312 ||| TO
2014  ||| S:312 E:317 ||| CD
in  ||| S:317 E:320 ||| IN
Beijing  ||| S:320 E:328 ||| NNP
to  ||| S:328 E:331 ||| TO
provide  ||| S:331 E:339 ||| VB
the  ||| S:339 E:343 ||| DT
scientific  ||| S:343 E:354 ||| JJ
evidence  ||| S:354 E:363 ||| NN
for  ||| S:363 E:367 ||| IN
prevention  ||| S:367 E:378 ||| NN
and  ||| S:378 E:382 ||| CC
treatment  ||| S:382 E:392 ||| NN
of  ||| S:392 E:395 ||| IN
HFMD ||| S:395 E:399 ||| NNP
.  ||| S:399 E:401 ||| .
During  ||| S:401 E:408 ||| IN
April  ||| S:408 E:414 ||| NNP
to  ||| S:414 E:417 ||| TO
September  ||| S:417 E:427 ||| NNP
in  ||| S:427 E:430 ||| IN
2013  ||| S:430 E:435 ||| CD
and  ||| S:435 E:439 ||| CC
March  ||| S:439 E:445 ||| NNP
to  ||| S:445 E:448 ||| TO
October  ||| S:448 E:456 ||| NNP
in  ||| S:456 E:459 ||| IN
2014 ||| S:459 E:463 ||| CD
,  ||| S:463 E:465 ||| ,
a  ||| S:465 E:467 ||| DT
total  ||| S:467 E:473 ||| NN
of  ||| S:473 E:476 ||| IN
977  ||| S:476 E:480 ||| CD
throat  ||| S:480 E:487 ||| CD
swabs  ||| S:487 E:493 ||| NNS
were  ||| S:493 E:498 ||| VBD
collected  ||| S:498 E:508 ||| VBN
from  ||| S:508 E:513 ||| IN
children  ||| S:513 E:522 ||| NNS
who  ||| S:522 E:526 ||| WP
visited  ||| S:526 E:534 ||| VBD
the  ||| S:534 E:538 ||| DT
Children ||| S:538 E:546 ||| NNP
's  ||| S:546 E:549 ||| POS
Hospital  ||| S:549 E:558 ||| NNP
Affiliated  ||| S:558 E:569 ||| NNP
to  ||| S:569 E:572 ||| TO
Capital  ||| S:572 E:580 ||| NNP
Institute  ||| S:580 E:590 ||| NNP
of  ||| S:590 E:593 ||| IN
Pediatrics ||| S:593 E:603 ||| NNP
,  ||| S:603 E:605 ||| ,
including  ||| S:605 E:615 ||| VBG
147  ||| S:615 E:619 ||| CD
from  ||| S:619 E:624 ||| IN
patients  ||| S:624 E:633 ||| NNS
with  ||| S:633 E:638 ||| IN
HFMD  ||| S:638 E:643 ||| NNP
in  ||| S:643 E:646 ||| IN
2013 ||| S:646 E:650 ||| CD
,  ||| S:650 E:652 ||| ,
343  ||| S:652 E:656 ||| CD
with  ||| S:656 E:661 ||| IN
HFMD ||| S:661 E:665 ||| NNP
,  ||| S:665 E:667 ||| ,
201  ||| S:667 E:671 ||| CD
with  ||| S:671 E:676 ||| IN
atypical  ||| S:676 E:685 ||| JJ
HFMD ||| S:685 E:689 ||| NNP
,  ||| S:689 E:691 ||| ,
83  ||| S:691 E:694 ||| CD
with  ||| S:694 E:699 ||| IN
herpangina ||| S:699 E:709 ||| NN
,  ||| S:709 E:711 ||| ,
25  ||| S:711 E:714 ||| CD
with  ||| S:714 E:719 ||| IN
fever  ||| S:719 E:725 ||| NN
with  ||| S:725 E:730 ||| IN
convulsions ||| S:730 E:741 ||| NNS
,  ||| S:741 E:743 ||| ,
64  ||| S:743 E:746 ||| CD
fever  ||| S:746 E:752 ||| NN
with  ||| S:752 E:757 ||| IN
rash  ||| S:757 E:762 ||| NN
and  ||| S:762 E:766 ||| CC
114  ||| S:766 E:770 ||| CD
with  ||| S:770 E:775 ||| IN
rash  ||| S:775 E:780 ||| NN
in  ||| S:780 E:783 ||| IN
2014 ||| S:783 E:787 ||| CD
.  ||| S:787 E:789 ||| .
Enteroviruses  ||| S:789 E:803 ||| JJ
universal  ||| S:803 E:813 ||| JJ
type  ||| S:813 E:818 ||| NN
( ||| S:818 E:819 ||| -LRB-
EV ||| S:819 E:821 ||| NNP
) ||| S:821 E:822 ||| -RRB-
,  ||| S:822 E:824 ||| ,
Enteroviruses  ||| S:824 E:838 ||| NNP
type  ||| S:838 E:843 ||| NN
71  ||| S:843 E:846 ||| CD
( ||| S:846 E:847 ||| -LRB-
EV71 ||| S:847 E:851 ||| NNP
)  ||| S:851 E:853 ||| -RRB-
and  ||| S:853 E:857 ||| CC
Coxsackievirus  ||| S:857 E:872 ||| NNP
group  ||| S:872 E:878 ||| NN
A  ||| S:878 E:880 ||| DT
16  ||| S:880 E:883 ||| CD
( ||| S:883 E:884 ||| -LRB-
CA16 ||| S:884 E:888 ||| NNP
)  ||| S:888 E:890 ||| -RRB-
were  ||| S:890 E:895 ||| VBD
detected  ||| S:895 E:904 ||| VBN
by  ||| S:904 E:907 ||| IN
real-time  ||| S:907 E:917 ||| JJ
RT-PCR  ||| S:917 E:924 ||| JJ
respectively ||| S:924 E:936 ||| NN
.  ||| S:936 E:938 ||| .
The  ||| S:938 E:942 ||| DT
nucleic  ||| S:942 E:950 ||| JJ
acid  ||| S:950 E:955 ||| NN
of  ||| S:955 E:958 ||| IN
specimens  ||| S:958 E:968 ||| NNS
which  ||| S:968 E:974 ||| WDT
were  ||| S:974 E:979 ||| VBD
identified  ||| S:979 E:990 ||| VBN
with  ||| S:990 E:995 ||| IN
non-EV71 ||| S:995 E:1003 ||| NNP
,  ||| S:1003 E:1005 ||| ,
non-CA16  ||| S:1005 E:1014 ||| NNP
was  ||| S:1014 E:1018 ||| VBD
tested  ||| S:1018 E:1025 ||| VBN
by  ||| S:1025 E:1028 ||| IN
nested  ||| S:1028 E:1035 ||| JJ
PCR  ||| S:1035 E:1039 ||| NNP
and  ||| S:1039 E:1043 ||| CC
analyzed  ||| S:1043 E:1052 ||| VBD
by  ||| S:1052 E:1055 ||| IN
VP1  ||| S:1055 E:1059 ||| CD
sequencing ||| S:1059 E:1069 ||| NNS
.  ||| S:1069 E:1071 ||| .
The  ||| S:1071 E:1075 ||| DT
detection  ||| S:1075 E:1085 ||| JJ
rate  ||| S:1085 E:1090 ||| NN
and  ||| S:1090 E:1094 ||| CC
epidemic  ||| S:1094 E:1103 ||| JJ
pattern  ||| S:1103 E:1111 ||| NN
of  ||| S:1111 E:1114 ||| IN
different  ||| S:1114 E:1124 ||| JJ
genotypes  ||| S:1124 E:1134 ||| NN
of  ||| S:1134 E:1137 ||| IN
enterovirus  ||| S:1137 E:1149 ||| NN
were  ||| S:1149 E:1154 ||| VBD
analyzed  ||| S:1154 E:1163 ||| VBN
among  ||| S:1163 E:1169 ||| IN
different  ||| S:1169 E:1179 ||| JJ
age  ||| S:1179 E:1183 ||| NN
groups  ||| S:1183 E:1190 ||| NNS
and  ||| S:1190 E:1194 ||| CC
between  ||| S:1194 E:1202 ||| IN
2013  ||| S:1202 E:1207 ||| CD
and  ||| S:1207 E:1211 ||| CC
2014 ||| S:1211 E:1215 ||| CD
.  ||| S:1215 E:1217 ||| .
Of  ||| S:1217 E:1220 ||| IN
977  ||| S:1220 E:1224 ||| CD
throat  ||| S:1224 E:1231 ||| JJ
swabs ||| S:1231 E:1236 ||| NN
,  ||| S:1236 E:1238 ||| ,
80.  ||| S:1238 E:1242 ||| CD
1 ||| S:1242 E:1243 ||| CD
%  ||| S:1243 E:1245 ||| NN
samples  ||| S:1245 E:1253 ||| NNS
were  ||| S:1253 E:1258 ||| VBD
detected  ||| S:1258 E:1267 ||| VBN
positive  ||| S:1267 E:1276 ||| JJ
for  ||| S:1276 E:1280 ||| IN
enteroviruses ||| S:1280 E:1293 ||| NN
.  ||| S:1293 E:1295 ||| .
The  ||| S:1295 E:1299 ||| DT
positive  ||| S:1299 E:1308 ||| JJ
rates  ||| S:1308 E:1314 ||| NNS
of  ||| S:1314 E:1317 ||| IN
CA16 ||| S:1317 E:1321 ||| NNP
,  ||| S:1321 E:1323 ||| ,
EV71 ||| S:1323 E:1327 ||| NNP
,  ||| S:1327 E:1329 ||| ,
CA6 ||| S:1329 E:1332 ||| NNP
,  ||| S:1332 E:1334 ||| ,
CA10 ||| S:1334 E:1338 ||| NNP
,  ||| S:1338 E:1340 ||| ,
CA4  ||| S:1340 E:1344 ||| NNP
and  ||| S:1344 E:1348 ||| CC
other  ||| S:1348 E:1354 ||| JJ
EVs  ||| S:1354 E:1358 ||| NN
were  ||| S:1358 E:1363 ||| VBD
25.  ||| S:1363 E:1367 ||| CD
6 ||| S:1367 E:1368 ||| CD
%  ||| S:1368 E:1370 ||| NN
( ||| S:1370 E:1371 ||| -LRB-
250 ||| S:1371 E:1374 ||| CD
/ ||| S:1374 E:1375 ||| CD
977 ||| S:1375 E:1378 ||| CD
) ||| S:1378 E:1379 ||| -RRB-
,  ||| S:1379 E:1381 ||| ,
18.  ||| S:1381 E:1385 ||| CD
9 ||| S:1385 E:1386 ||| CD
%  ||| S:1386 E:1388 ||| NN
( ||| S:1388 E:1389 ||| -LRB-
185 ||| S:1389 E:1392 ||| CD
/ ||| S:1392 E:1393 ||| CD
977 ||| S:1393 E:1396 ||| CD
) ||| S:1396 E:1397 ||| -RRB-
,  ||| S:1397 E:1399 ||| ,
20.  ||| S:1399 E:1403 ||| CD
0 ||| S:1403 E:1404 ||| CD
%  ||| S:1404 E:1406 ||| NN
( ||| S:1406 E:1407 ||| -LRB-
195 ||| S:1407 E:1410 ||| CD
/ ||| S:1410 E:1411 ||| CD
977 ||| S:1411 E:1414 ||| CD
) ||| S:1414 E:1415 ||| -RRB-
,  ||| S:1415 E:1417 ||| ,
5.  ||| S:1417 E:1420 ||| CD
0 ||| S:1420 E:1421 ||| CD
%  ||| S:1421 E:1423 ||| NN
( ||| S:1423 E:1424 ||| -LRB-
49 ||| S:1424 E:1426 ||| CD
/ ||| S:1426 E:1427 ||| CD
977 ||| S:1427 E:1430 ||| CD
) ||| S:1430 E:1431 ||| -RRB-
,  ||| S:1431 E:1433 ||| ,
1.5 ||| S:1433 E:1436 ||| CD
%  ||| S:1436 E:1438 ||| NN
( ||| S:1438 E:1439 ||| -LRB-
15 ||| S:1439 E:1441 ||| CD
/ ||| S:1441 E:1442 ||| CD
977 ||| S:1442 E:1445 ||| CD
)  ||| S:1445 E:1447 ||| -RRB-
and  ||| S:1447 E:1451 ||| CC
9.1 ||| S:1451 E:1454 ||| CD
%  ||| S:1454 E:1456 ||| NN
( ||| S:1456 E:1457 ||| -LRB-
89 ||| S:1457 E:1459 ||| CD
/ ||| S:1459 E:1460 ||| CD
977 ||| S:1460 E:1463 ||| CD
) ||| S:1463 E:1464 ||| -RRB-
,  ||| S:1464 E:1466 ||| ,
respectively ||| S:1466 E:1478 ||| RB
.  ||| S:1478 E:1480 ||| .
Twenty  ||| S:1480 E:1487 ||| CD
six  ||| S:1487 E:1491 ||| CD
of  ||| S:1491 E:1494 ||| IN
the  ||| S:1494 E:1498 ||| DT
89  ||| S:1498 E:1501 ||| CD
other  ||| S:1501 E:1507 ||| JJ
EVs  ||| S:1507 E:1511 ||| NN
included  ||| S:1511 E:1520 ||| VBD
CA2 ||| S:1520 E:1523 ||| CD
,  ||| S:1523 E:1525 ||| ,
CA5 ||| S:1525 E:1528 ||| NNP
,  ||| S:1528 E:1530 ||| ,
CA8 ||| S:1530 E:1533 ||| NNP
,  ||| S:1533 E:1535 ||| ,
CA9 ||| S:1535 E:1538 ||| NNP
,  ||| S:1538 E:1540 ||| ,
CA12 ||| S:1540 E:1544 ||| NNP
,  ||| S:1544 E:1546 ||| ,
CA14 ||| S:1546 E:1550 ||| NNP
,  ||| S:1550 E:1552 ||| ,
CB2 ||| S:1552 E:1555 ||| NNP
,  ||| S:1555 E:1557 ||| ,
CB5 ||| S:1557 E:1560 ||| NNP
,  ||| S:1560 E:1562 ||| ,
E6 ||| S:1562 E:1564 ||| NNP
,  ||| S:1564 E:1566 ||| ,
E9  ||| S:1566 E:1569 ||| NNP
and  ||| S:1569 E:1573 ||| CC
E25 ||| S:1573 E:1576 ||| NNP
,  ||| S:1576 E:1578 ||| ,
each  ||| S:1578 E:1583 ||| DT
genotype  ||| S:1583 E:1592 ||| NN
of  ||| S:1592 E:1595 ||| IN
which  ||| S:1595 E:1601 ||| WDT
was  ||| S:1601 E:1605 ||| VBD
no  ||| S:1605 E:1608 ||| DT
more  ||| S:1608 E:1613 ||| JJR
than  ||| S:1613 E:1618 ||| IN
3 ||| S:1618 E:1619 ||| CD
.  ||| S:1619 E:1621 ||| .
The  ||| S:1621 E:1625 ||| DT
nucleotide  ||| S:1625 E:1636 ||| JJ
homologies  ||| S:1636 E:1647 ||| NNS
shared  ||| S:1647 E:1654 ||| VBN
among  ||| S:1654 E:1660 ||| IN
CA6 ||| S:1660 E:1663 ||| NNP
,  ||| S:1663 E:1665 ||| ,
CA10  ||| S:1665 E:1670 ||| NNP
and  ||| S:1670 E:1674 ||| CC
CA4  ||| S:1674 E:1678 ||| CD
strains  ||| S:1678 E:1686 ||| NNS
between  ||| S:1686 E:1694 ||| IN
2013  ||| S:1694 E:1699 ||| CD
and  ||| S:1699 E:1703 ||| CC
2014  ||| S:1703 E:1708 ||| CD
were  ||| S:1708 E:1713 ||| VBD
94.  ||| S:1713 E:1717 ||| CD
3 ||| S:1717 E:1718 ||| CD
%  ||| S:1718 E:1720 ||| NN
-  ||| S:1720 E:1722 ||| :
100 ||| S:1722 E:1725 ||| CD
% ||| S:1725 E:1726 ||| NN
,  ||| S:1726 E:1728 ||| ,
93.  ||| S:1728 E:1732 ||| CD
8 ||| S:1732 E:1733 ||| CD
%  ||| S:1733 E:1735 ||| NN
-  ||| S:1735 E:1737 ||| :
99.  ||| S:1737 E:1741 ||| CD
1 ||| S:1741 E:1742 ||| CD
%  ||| S:1742 E:1744 ||| NN
and  ||| S:1744 E:1748 ||| CC
92.7 ||| S:1748 E:1752 ||| CD
%  ||| S:1752 E:1754 ||| NN
-  ||| S:1754 E:1756 ||| :
99.  ||| S:1756 E:1760 ||| CD
8 ||| S:1760 E:1761 ||| CD
% ||| S:1761 E:1762 ||| NN
,  ||| S:1762 E:1764 ||| ,
respectively ||| S:1764 E:1776 ||| RB
.  ||| S:1776 E:1778 ||| .
The  ||| S:1778 E:1782 ||| DT
positive  ||| S:1782 E:1791 ||| JJ
rates  ||| S:1791 E:1797 ||| NNS
of  ||| S:1797 E:1800 ||| IN
≤1  ||| S:1800 E:1803 ||| CD
year  ||| S:1803 E:1808 ||| NN
group  ||| S:1808 E:1814 ||| NN
were  ||| S:1814 E:1819 ||| VBD
71.  ||| S:1819 E:1823 ||| CD
1 ||| S:1823 E:1824 ||| CD
%  ||| S:1824 E:1826 ||| NN
( ||| S:1826 E:1827 ||| -LRB-
106 ||| S:1827 E:1830 ||| CD
/ ||| S:1830 E:1831 ||| CD
149 ||| S:1831 E:1834 ||| CD
) ||| S:1834 E:1835 ||| -RRB-
,  ||| S:1835 E:1837 ||| ,
which  ||| S:1837 E:1843 ||| WDT
was  ||| S:1843 E:1847 ||| VBD
lower  ||| S:1847 E:1853 ||| JJR
than  ||| S:1853 E:1858 ||| IN
that  ||| S:1858 E:1863 ||| DT
of  ||| S:1863 E:1866 ||| IN
other  ||| S:1866 E:1872 ||| JJ
age  ||| S:1872 E:1876 ||| NN
groups  ||| S:1876 E:1883 ||| NNS
( ||| S:1883 E:1884 ||| -LRB-
all  ||| S:1884 E:1888 ||| DT
P  ||| S:1888 E:1890 ||| NN
< ||| S:1890 E:1891 ||| SYM
0.  ||| S:1891 E:1894 ||| CD
05 ||| S:1894 E:1896 ||| CD
) ||| S:1896 E:1897 ||| -RRB-
,  ||| S:1897 E:1899 ||| ,
but  ||| S:1899 E:1903 ||| CC
similar  ||| S:1903 E:1911 ||| JJ
to  ||| S:1911 E:1914 ||| TO
that  ||| S:1914 E:1919 ||| DT
of  ||| S:1919 E:1922 ||| IN
> ||| S:1922 E:1923 ||| CD
5  ||| S:1923 E:1925 ||| CD
year  ||| S:1925 E:1930 ||| NN
group  ||| S:1930 E:1936 ||| NN
( ||| S:1936 E:1937 ||| -LRB-
χ2  ||| S:1937 E:1940 ||| CD
=1.  ||| S:1940 E:1944 ||| CD
181 ||| S:1944 E:1947 ||| CD
, ||| S:1947 E:1948 ||| ,
P  ||| S:1948 E:1950 ||| NN
=  ||| S:1950 E:1952 ||| SYM
0.  ||| S:1952 E:1955 ||| CD
277 ||| S:1955 E:1958 ||| CD
) ||| S:1958 E:1959 ||| -RRB-
.  ||| S:1959 E:1961 ||| .
In  ||| S:1961 E:1964 ||| IN
2013 ||| S:1964 E:1968 ||| CD
,  ||| S:1968 E:1970 ||| ,
the  ||| S:1970 E:1974 ||| DT
positive  ||| S:1974 E:1983 ||| JJ
rate  ||| S:1983 E:1988 ||| NN
of  ||| S:1988 E:1991 ||| IN
EV  ||| S:1991 E:1994 ||| NNP
was  ||| S:1994 E:1998 ||| VBD
85.  ||| S:1998 E:2002 ||| CD
7 ||| S:2002 E:2003 ||| CD
%  ||| S:2003 E:2005 ||| NN
( ||| S:2005 E:2006 ||| -LRB-
126 ||| S:2006 E:2009 ||| CD
/ ||| S:2009 E:2010 ||| CD
147 ||| S:2010 E:2013 ||| CD
)  ||| S:2013 E:2015 ||| -RRB-
and  ||| S:2015 E:2019 ||| CC
the  ||| S:2019 E:2023 ||| DT
predominant  ||| S:2023 E:2035 ||| JJ
genotype  ||| S:2035 E:2044 ||| NN
was  ||| S:2044 E:2048 ||| VBD
CA6  ||| S:2048 E:2052 ||| CD
54.  ||| S:2052 E:2056 ||| CD
8 ||| S:2056 E:2057 ||| CD
%  ||| S:2057 E:2059 ||| NN
( ||| S:2059 E:2060 ||| -LRB-
69 ||| S:2060 E:2062 ||| CD
/ ||| S:2062 E:2063 ||| CD
126 ||| S:2063 E:2066 ||| CD
) ||| S:2066 E:2067 ||| -RRB-
,  ||| S:2067 E:2069 ||| ,
followed  ||| S:2069 E:2078 ||| VBN
by  ||| S:2078 E:2081 ||| IN
CA16  ||| S:2081 E:2086 ||| CD
20.  ||| S:2086 E:2090 ||| CD
6 ||| S:2090 E:2091 ||| CD
%  ||| S:2091 E:2093 ||| NN
( ||| S:2093 E:2094 ||| -LRB-
26 ||| S:2094 E:2096 ||| CD
/ ||| S:2096 E:2097 ||| CD
126 ||| S:2097 E:2100 ||| CD
)  ||| S:2100 E:2102 ||| -RRB-
and  ||| S:2102 E:2106 ||| CC
EV71  ||| S:2106 E:2111 ||| CD
11.  ||| S:2111 E:2115 ||| CD
9 ||| S:2115 E:2116 ||| CD
%  ||| S:2116 E:2118 ||| NN
( ||| S:2118 E:2119 ||| -LRB-
15 ||| S:2119 E:2121 ||| CD
/ ||| S:2121 E:2122 ||| CD
126 ||| S:2122 E:2125 ||| CD
) ||| S:2125 E:2126 ||| -RRB-
.  ||| S:2126 E:2128 ||| .
In  ||| S:2128 E:2131 ||| IN
2014 ||| S:2131 E:2135 ||| CD
,  ||| S:2135 E:2137 ||| ,
the  ||| S:2137 E:2141 ||| DT
positive  ||| S:2141 E:2150 ||| JJ
rate  ||| S:2150 E:2155 ||| NN
of  ||| S:2155 E:2158 ||| IN
EV  ||| S:2158 E:2161 ||| NNP
was  ||| S:2161 E:2165 ||| VBD
85.  ||| S:2165 E:2169 ||| CD
4 ||| S:2169 E:2170 ||| CD
%  ||| S:2170 E:2172 ||| NN
( ||| S:2172 E:2173 ||| -LRB-
293 ||| S:2173 E:2176 ||| CD
/ ||| S:2176 E:2177 ||| CD
343 ||| S:2177 E:2180 ||| CD
)  ||| S:2180 E:2182 ||| -RRB-
in  ||| S:2182 E:2185 ||| IN
the  ||| S:2185 E:2189 ||| DT
343  ||| S:2189 E:2193 ||| CD
children  ||| S:2193 E:2202 ||| NNS
with  ||| S:2202 E:2207 ||| IN
HFMD ||| S:2207 E:2211 ||| NNP
,  ||| S:2211 E:2213 ||| ,
the  ||| S:2213 E:2217 ||| DT
predominant  ||| S:2217 E:2229 ||| JJ
genotypes  ||| S:2229 E:2239 ||| NN
were  ||| S:2239 E:2244 ||| VBD
CA16  ||| S:2244 E:2249 ||| CD
with  ||| S:2249 E:2254 ||| IN
the  ||| S:2254 E:2258 ||| DT
positive  ||| S:2258 E:2267 ||| JJ
rate  ||| S:2267 E:2272 ||| NN
of  ||| S:2272 E:2275 ||| IN
42.  ||| S:2275 E:2279 ||| CD
7 ||| S:2279 E:2280 ||| CD
%  ||| S:2280 E:2282 ||| NN
( ||| S:2282 E:2283 ||| -LRB-
125 ||| S:2283 E:2286 ||| CD
/ ||| S:2286 E:2287 ||| CD
293 ||| S:2287 E:2290 ||| CD
) ||| S:2290 E:2291 ||| -RRB-
,  ||| S:2291 E:2293 ||| ,
EV71  ||| S:2293 E:2298 ||| NNP
with  ||| S:2298 E:2303 ||| IN
38.  ||| S:2303 E:2307 ||| CD
2 ||| S:2307 E:2308 ||| CD
%  ||| S:2308 E:2310 ||| NN
( ||| S:2310 E:2311 ||| -LRB-
112 ||| S:2311 E:2314 ||| CD
/ ||| S:2314 E:2315 ||| CD
293 ||| S:2315 E:2318 ||| CD
)  ||| S:2318 E:2320 ||| -RRB-
and  ||| S:2320 E:2324 ||| CC
CA6  ||| S:2324 E:2328 ||| CD
with  ||| S:2328 E:2333 ||| IN
only  ||| S:2333 E:2338 ||| RB
11.  ||| S:2338 E:2342 ||| CD
3 ||| S:2342 E:2343 ||| CD
%  ||| S:2343 E:2345 ||| NN
( ||| S:2345 E:2346 ||| -LRB-
33 ||| S:2346 E:2348 ||| CD
/ ||| S:2348 E:2349 ||| CD
293 ||| S:2349 E:2352 ||| CD
) ||| S:2352 E:2353 ||| -RRB-
.  ||| S:2353 E:2355 ||| .
In  ||| S:2355 E:2358 ||| IN
2014 ||| S:2358 E:2362 ||| CD
,  ||| S:2362 E:2364 ||| ,
the  ||| S:2364 E:2368 ||| DT
positive  ||| S:2368 E:2377 ||| JJ
rates  ||| S:2377 E:2383 ||| NNS
of  ||| S:2383 E:2386 ||| IN
EV  ||| S:2386 E:2389 ||| NNP
in  ||| S:2389 E:2392 ||| IN
201  ||| S:2392 E:2396 ||| CD
atypical  ||| S:2396 E:2405 ||| JJ
HFMD ||| S:2405 E:2409 ||| NNP
,  ||| S:2409 E:2411 ||| ,
83  ||| S:2411 E:2414 ||| CD
herpangina ||| S:2414 E:2424 ||| NN
,  ||| S:2424 E:2426 ||| ,
25  ||| S:2426 E:2429 ||| CD
fever  ||| S:2429 E:2435 ||| NN
with  ||| S:2435 E:2440 ||| IN
convulsions ||| S:2440 E:2451 ||| NNS
,  ||| S:2451 E:2453 ||| ,
64  ||| S:2453 E:2456 ||| CD
fever  ||| S:2456 E:2462 ||| NN
with  ||| S:2462 E:2467 ||| IN
rash  ||| S:2467 E:2472 ||| NN
and  ||| S:2472 E:2476 ||| CC
114  ||| S:2476 E:2480 ||| CD
rash  ||| S:2480 E:2485 ||| NN
were  ||| S:2485 E:2490 ||| VBD
83.  ||| S:2490 E:2494 ||| CD
6 ||| S:2494 E:2495 ||| CD
%  ||| S:2495 E:2497 ||| NN
( ||| S:2497 E:2498 ||| -LRB-
168 ||| S:2498 E:2501 ||| CD
/ ||| S:2501 E:2502 ||| CD
201 ||| S:2502 E:2505 ||| CD
) ||| S:2505 E:2506 ||| -RRB-
,  ||| S:2506 E:2508 ||| ,
80.  ||| S:2508 E:2512 ||| CD
7 ||| S:2512 E:2513 ||| CD
%  ||| S:2513 E:2515 ||| NN
( ||| S:2515 E:2516 ||| -LRB-
67 ||| S:2516 E:2518 ||| CD
/ ||| S:2518 E:2519 ||| CD
83 ||| S:2519 E:2521 ||| CD
) ||| S:2521 E:2522 ||| -RRB-
,  ||| S:2522 E:2524 ||| ,
76.  ||| S:2524 E:2528 ||| CD
0 ||| S:2528 E:2529 ||| CD
%  ||| S:2529 E:2531 ||| NN
( ||| S:2531 E:2532 ||| -LRB-
19 ||| S:2532 E:2534 ||| CD
/ ||| S:2534 E:2535 ||| CD
25 ||| S:2535 E:2537 ||| CD
) ||| S:2537 E:2538 ||| -RRB-
,  ||| S:2538 E:2540 ||| ,
64.  ||| S:2540 E:2544 ||| CD
1 ||| S:2544 E:2545 ||| CD
%  ||| S:2545 E:2547 ||| NN
( ||| S:2547 E:2548 ||| -LRB-
41 ||| S:2548 E:2550 ||| CD
/ ||| S:2550 E:2551 ||| CD
64 ||| S:2551 E:2553 ||| CD
)  ||| S:2553 E:2555 ||| -RRB-
and  ||| S:2555 E:2559 ||| CC
60.  ||| S:2559 E:2563 ||| CD
5 ||| S:2563 E:2564 ||| CD
%  ||| S:2564 E:2566 ||| NN
( ||| S:2566 E:2567 ||| -LRB-
69 ||| S:2567 E:2569 ||| CD
/ ||| S:2569 E:2570 ||| CD
114 ||| S:2570 E:2573 ||| CD
) ||| S:2573 E:2574 ||| -RRB-
,  ||| S:2574 E:2576 ||| ,
respectively ||| S:2576 E:2588 ||| RB
.  ||| S:2588 E:2590 ||| .
All  ||| S:2590 E:2594 ||| DT
genotypes  ||| S:2594 E:2604 ||| NN
of  ||| S:2604 E:2607 ||| IN
enteroviruses  ||| S:2607 E:2621 ||| NN
peaked  ||| S:2621 E:2628 ||| VBD
mainly  ||| S:2628 E:2635 ||| RB
during  ||| S:2635 E:2642 ||| IN
May  ||| S:2642 E:2646 ||| NNP
to  ||| S:2646 E:2649 ||| TO
August  ||| S:2649 E:2656 ||| NNP
every  ||| S:2656 E:2662 ||| DT
year ||| S:2662 E:2666 ||| NN
,  ||| S:2666 E:2668 ||| ,
but  ||| S:2668 E:2672 ||| CC
there  ||| S:2672 E:2678 ||| EX
were  ||| S:2678 E:2683 ||| VBD
no  ||| S:2683 E:2686 ||| DT
obvious  ||| S:2686 E:2694 ||| JJ
epidemiological  ||| S:2694 E:2710 ||| JJ
pattern  ||| S:2710 E:2718 ||| NN
about  ||| S:2718 E:2724 ||| IN
each  ||| S:2724 E:2729 ||| DT
genotype ||| S:2729 E:2737 ||| NN
.  ||| S:2737 E:2739 ||| .
CA6  ||| S:2739 E:2743 ||| NNP
became  ||| S:2743 E:2750 ||| VBD
the  ||| S:2750 E:2754 ||| DT
main  ||| S:2754 E:2759 ||| JJ
causative  ||| S:2759 E:2769 ||| JJ
agent  ||| S:2769 E:2775 ||| NN
of  ||| S:2775 E:2778 ||| IN
HFMD  ||| S:2778 E:2783 ||| NNP
in  ||| S:2783 E:2786 ||| IN
2013 ||| S:2786 E:2790 ||| CD
,  ||| S:2790 E:2792 ||| ,
however ||| S:2792 E:2799 ||| RB
,  ||| S:2799 E:2801 ||| ,
CA16  ||| S:2801 E:2806 ||| NNP
and  ||| S:2806 E:2810 ||| CC
EV71  ||| S:2810 E:2815 ||| NNP
predominated  ||| S:2815 E:2828 ||| VBD
again  ||| S:2828 E:2834 ||| RB
in  ||| S:2834 E:2837 ||| IN
2014  ||| S:2837 E:2842 ||| CD
in  ||| S:2842 E:2845 ||| IN
Beijing ||| S:2845 E:2852 ||| NNP
.  ||| S:2852 E:2854 ||| .
The  ||| S:2854 E:2858 ||| DT
clinical  ||| S:2858 E:2867 ||| JJ
manifestations  ||| S:2867 E:2882 ||| NNS
caused  ||| S:2882 E:2889 ||| VBN
by  ||| S:2889 E:2892 ||| IN
CA6 ||| S:2892 E:2895 ||| NNP
,  ||| S:2895 E:2897 ||| ,
CA10 ||| S:2897 E:2901 ||| NNP
,  ||| S:2901 E:2903 ||| ,
CA4  ||| S:2903 E:2907 ||| NNP
and  ||| S:2907 E:2911 ||| CC
other  ||| S:2911 E:2917 ||| JJ
genotype  ||| S:2917 E:2926 ||| NN
of  ||| S:2926 E:2929 ||| IN
enteroviruses  ||| S:2929 E:2943 ||| JJ
differed  ||| S:2943 E:2952 ||| NN
from  ||| S:2952 E:2957 ||| IN
EV71  ||| S:2957 E:2962 ||| NNP
and  ||| S:2962 E:2966 ||| CC
CA16 ||| S:2966 E:2970 ||| NNP
.  ||| S:2970 E:2972 ||| .
Besides  ||| S:2972 E:2980 ||| IN
EV71  ||| S:2980 E:2985 ||| NNP
and  ||| S:2985 E:2989 ||| CC
CA16 ||| S:2989 E:2993 ||| NNP
,  ||| S:2993 E:2995 ||| ,
more  ||| S:2995 E:3000 ||| JJR
attention  ||| S:3000 E:3010 ||| NN
should  ||| S:3010 E:3017 ||| MD
be  ||| S:3017 E:3020 ||| VB
paid  ||| S:3020 E:3025 ||| VBN
to  ||| S:3025 E:3028 ||| TO
CA6 ||| S:3028 E:3031 ||| CD
,  ||| S:3031 E:3033 ||| ,
CA10 ||| S:3033 E:3037 ||| NNP
,  ||| S:3037 E:3039 ||| ,
CA4  ||| S:3039 E:3043 ||| NNP
and  ||| S:3043 E:3047 ||| CC
other  ||| S:3047 E:3053 ||| JJ
type  ||| S:3053 E:3058 ||| NN
of  ||| S:3058 E:3061 ||| IN
enteroviruses ||| S:3061 E:3074 ||| NN
.  ||| S:3074 E:3076 ||| .
[ ||| S:3076 E:3077 ||| -LRB-
Key  ||| S:3077 E:3081 ||| JJ
words ||| S:3081 E:3086 ||| NNS
]  ||| S:3086 E:3088 ||| -RRB-
Hand ||| S:3088 E:3092 ||| NNP
,  ||| S:3092 E:3094 ||| ,
foot  ||| S:3094 E:3099 ||| NN
and  ||| S:3099 E:3103 ||| CC
mouth  ||| S:3103 E:3109 ||| NN
disease ||| S:3109 E:3116 ||| NN
;  ||| S:3116 E:3118 ||| :
Enterovirus ||| S:3118 E:3129 ||| NNP
;  ||| S:3129 E:3131 ||| :
Genotype ||| S:3131 E:3139 ||| NNP
;  ||| S:3139 E:3141 ||| :
Child  ||| S:3141 E:3147 ||| LS
